Patients Discontinuing Anti-Obesity Medications Put On Weight Far More Rapidly Compared to People Using Diet and Exercise

New research suggests that individuals who come off new slimming jabs like Wegovy and Mounjaro may regain lost weight far faster than those who end traditional lifestyle regimens.

Published data in a leading medical journal shows that while obese people frequently drop a large proportion of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"Users purchasing these treatments should be informed of the danger of quick weight regain when the treatment concludes," cautioned researcher Dr. Susan Jebb.

Such speed of recovery implies a return to starting mass within about one and a half years.

Weighing Treatments

The analysis, which examined dozens of studies involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with other pills.

Scientists point out that people who lose weight through diet and exercise generally experience a slower weight regain—around 100 grams monthly—after stopping.

Understanding the Fast Regain

Doctors propose the way of the jabs is key to understanding the accelerated regain.

GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.

"Artificially providing GLP-1 concentrations far above than normal may cause the system to produce less of its own natural hormone, and could lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.

"Withdrawal of this GLP-1 'fix' means hunger is uncontrolled, making binge eating much more probable."

A Lifelong Disease?

The NHS suggest the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

Professionals contend that, given the high risk of relapse, the treatment should be considered long-term.

This opinion is echoed by drug manufacturers, who note that the findings "emphasize the chronic character of excess weight," akin to managing diseases like high blood pressure.

Patient Accounts

Individuals who have discontinued the jabs describe a intense resurgence of hunger.

"It felt as if a switch flipping and you become extremely hungry," described an individual.

This difficulty is exacerbated if individuals have not developed permanent dietary or behavioural modifications during treatment.

Significant Adoption

Recent estimates show that millions of people in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.

• Use is greater among females compared to males.
• The 40s and 50s demographic shows the highest level of interest.
• A large proportion access the drugs through private prescriptions rather than public health services.

In conclusion, researchers caution that while GLP-1 drugs are potent agents for weight loss, they are not a magic solution and lasting health benefits likely depends on combined lifestyle management.